No Data
No Data
Avidity Biosciences to Participate in Upcoming Investor Conferences
Possible Bearish Signals With Avidity Biosciences Insiders Disposing Stock
We're Hopeful That Avidity Biosciences (NASDAQ:RNA) Will Use Its Cash Wisely
Insider Sale: Director at $RNA Sells 1,872 Shares
RBC Capital Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $67
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)